Health Professionals

This webpage explain how LGBTQ+ young people are not inherently prone to suicide risk because of their sexual orientation or gender identity but rather placed at higher risk because of how they are mistreated and stigmatized in society.

This counseling guide summarizes recommendations from the U.S. Department of Health and Human Services Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission regarding the use of antiretroviral (ARV) drugs during pregnancy or when trying to conceive. Its purpose is to support informed, shared decision-making for individuals living with HIV and their clinicians. Effective antiretroviral therapy (ART) with sustained viral suppression is the cornerstone of maternal health and prevention of perinatal HIV transmission.

The 2024 US Preventive Services Task Force (USPSTF) Recommendation Statement reaffirms the importance of early screening for syphilis infection in all pregnant individuals to prevent congenital syphilis and associated complications. The report underscores timely testing—including repeat screening in high-risk cases—as a critical measure to safeguard maternal and infant health.

This webpage explains that persistent high-risk HPV—especially type 16—is a leading cause of oropharyngeal cancer, accounting for around 70% of U.S. throat cancers, and highlights prevention strategies like vaccination, sexual health practices, and regular screenings.

This fact sheet outlines that herpes simplex virus (HSV‑1 and HSV‑2) is a common, lifelong infection causing oral or genital blisters, transmitted via skin-to-skin or saliva contact—even when asymptomatic—and managed through antiviral treatment and preventive measures. It emphasizes that many individuals are unaware of their infection and underscores the role of condoms and suppressive therapy in reducing symptom recurrence and transmission.

This report describes a newborn diagnosed with congenital syphilis, born to an adolescent mother without routine prenatal care. Despite initial diagnostic challenges, timely testing and treatment led to a positive outcome in accordance with national guidelines.

This guideline compiles up-to-date legal requirements across all U.S. states and territories, clarifying when healthcare providers and laboratories must report negative Hepatitis C test outcomes. It offers a clear, state-by-state breakdown to help public health entities and providers comply with surveillance obligations and improve data completeness.

This guideline presents a comprehensive state-by-state legal analysis of obligations for healthcare providers and laboratories to report negative HIV test outcomes. It clearly highlights jurisdictional differences, helping public health officials and clinicians ensure compliance with surveillance mandates and improve disease tracking.